Evaluating the potential impact of rubella-containing vaccine introduction on congenital rubella syndrome in Afghanistan, Dem. Republic of Congo, Ethiopia, Nigeria, and Pakistan: A mathematical modeling study

• Published in: PLOS global public health 2024, Vol.4 (1), p.e0002656
• Main Authors: Rodriguez-Cartes, Sebastian A, Zhang, Yiwei, Mayorga, Maria E, Swann, Julie L, Allaire, Benjamin T
• Format: Article
• Language: English
• Subjects: Biology and Life Sciences; Medicine and Health Sciences; People and Places
• ISSN: 2767-3375; 2767-3375
• DOI: 10.1371/journal.pgph.0002656

We assessed the potential impact of introducing rubella-containing vaccine (RCV) on congenital rubella syndrome (CRS) incidence in Afghanistan (AFG), Democratic Republic of Congo (COD), Ethiopia (ETH), Nigeria (NGA), and Pakistan (PAK). We simulated several RCV introduction scenarios over 30 years using a validated mathematical model. Our findings indicate that RCV introduction could avert between 86,000 and 535,000 CRS births, preventing 2.5 to 15.8 million disability-adjusted life years. AFG and PAK could reduce about 90% of CRS births by introducing RCV with current measles routine coverage and executing supplemental immunization activities (SIAs). However, COD, NGA, and ETH must increase their current routine vaccination coverage to reduce CRS incidence significantly. This study showcases the potential benefits of RCV introduction and reinforces the need for global action to strengthen immunization programs.